Thynestron en es it fr

Thynestron Brand names, Thynestron Analogs

Thynestron Brand Names Mixture

  • Cimicifuga Plex (Caulophyllum Thalictroides + Cimicifuga Racemosa + Copper + Cotton Plant + Estrone + Histamine Dihydrochloride + Hypothalamus + Magnesium Phosphate Dibasic + Pituitary Whole + Platinum + Sepia Officinalis L + Thyroid)
  • Holis 98 (Dioscorea Vilosa + Estrone + Salvia + Saw Palmetto)

Thynestron Chemical_Formula

C18H22O2

Thynestron RX_link

No information avaliable

Thynestron fda sheet

Thynestron msds (material safety sheet)

Thynestron MSDS

Thynestron Synthesis Reference

G. Anner, K. Miescher, and Helv. Chem. Acta. 31, 2173(1948)

Thynestron Molecular Weight

270.366 g/mol

Thynestron Melting Point

254.5-256 oC

Thynestron H2O Solubility

3 g/100mL

Thynestron State

Solid

Thynestron LogP

4.067

Thynestron Dosage Forms

Vaginal cream; Vaginal suppository; Patch; Skin gel; Tablet; IM injectable suspension

Thynestron Indication

For management of Menopausal and postmenopausal disorders

Thynestron Pharmacology

Estrone, a synthetically prepared or naturally occurring steroidal estrogen obtained from pregnant equine urine, is the primary circulating estrogen after menopause. Estrone is naturally derived from the peripheral conversion of androstenedione by an aromatase enzyme found in adipose tissues and is converted to estradiol in peripheral tissues. Estropipate is piperazine-stabilized estrone sulfate. Estrone, and estropipate are used to treat abnormalities related to gonadotropin hormone dysfunction, vasomotor symptoms, atrophic vaginitis, and vulvar atrophy associated with menopause, and for the prevention of osteoporosis due to estrogen deficiency.

Thynestron Absorption

43%

Thynestron side effects and Toxicity

Symptoms of overdose include nausea and vomiting. Withdrawal bleeding may occur in females.

Thynestron Patient Information

Thynestron Organisms Affected

Humans and other mammals